Evidence map›Paper›PMID 30140280›Full record

ArticleGastroenterology research and practice2018

Computed Tomography Enterography: Quantitative Evaluation on Crohn's Disease Activity.

Jingyun Cheng, Hui Xie, Hao Yang, Ke Wang, Guobin Xu, Guangyao Wu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [European journal of nuclear medicine and molecular imaging · 2023
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jingyun ChengDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.ORCID 0000-0002-4097-1712
Hui XieDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.
Hao YangDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.
Ke WangDepartment of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.
Guobin XuDepartment of Radiology, Zhongshan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.
Guangyao WuDepartment of Magnetic Resonance Imaging, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province 430071, China.ORCID 0000-0002-0456-3682
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the feasibility of computed tomography enterography (CTE) in the quantitative evaluation of the activity of Crohn's disease (CD).

methodsThere were 49 CD patients with whole clinical, enteroscopy, and CTE data to be analyzed retrospectively. The patients were graded as inactive (0-2), mild (3-6), and moderate-severe group (>6) based on simplified endoscopic activity score for Crohn's disease (SES-CD). The differences in bowel wall thickening, mural hyperenhancement in the portal vein period, and the ΔCT values were analyzed among groups using ANOVA (analysis of variance) and

resultsIn the 49 patients, 13 ones were inactive, 19 ones were mild, and 17 ones were moderate-severe; the thickness of bowel wall, mural hyperenhancement in the portal vein period, and ΔCT value among groups were all significantly different (

conclusionThe mural hyperenhancement in the portal vein period, bowel wall thickening, and ΔCT value can accurately and quantitatively assess the activity of CD lesions and are potential visual biomarkers of CD lesions.

Identifiers

PMID30140280
PMCPMC6081582
OpenAlexW2883068134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.